Bonus Biogroup Stock Return On Equity
| BBIXF Stock | USD 0.02 0.00 0.00% |
Bonus BioGroup fundamentals help investors to digest information that contributes to Bonus BioGroup's financial success or failures. It also enables traders to predict the movement of Bonus Pink Sheet. The fundamental analysis module provides a way to measure Bonus BioGroup's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bonus BioGroup pink sheet.
Bonus |
Bonus BioGroup Company Return On Equity Analysis
Bonus BioGroup's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Bonus BioGroup Return On Equity | -0.55 |
Most of Bonus BioGroup's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bonus BioGroup is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Bonus BioGroup has a Return On Equity of -0.5522. This is 97.7% lower than that of the Healthcare sector and 98.49% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 78.13% higher than that of the company.
Bonus Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bonus BioGroup's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bonus BioGroup could also be used in its relative valuation, which is a method of valuing Bonus BioGroup by comparing valuation metrics of similar companies.Bonus BioGroup is currently under evaluation in return on equity category among its peers.
Bonus Fundamentals
| Return On Equity | -0.55 | |||
| Return On Asset | -0.0636 | |||
| Current Valuation | 48.99 M | |||
| Shares Outstanding | 1.17 B | |||
| Shares Owned By Insiders | 49.72 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Book | 4.05 X | |||
| EBITDA | (88.03 M) | |||
| Net Income | (90.08 M) | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 9.13 X | |||
| Cash Flow From Operations | (39.84 M) | |||
| Beta | 1.4 | |||
| Market Capitalization | 62.59 M | |||
| Total Asset | 104.32 M | |||
| Net Asset | 104.32 M |
About Bonus BioGroup Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bonus BioGroup's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bonus BioGroup using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bonus BioGroup based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bonus Pink Sheet
Bonus BioGroup financial ratios help investors to determine whether Bonus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonus with respect to the benefits of owning Bonus BioGroup security.